Chemical Compound

Lanreotide

CAS Registry Number 108736-35-2
Back to search Request a Quote
Lanreotide chemical structure
Primary Record

Lanreotide

In stock
1,403 g
Purity
99.7 %
CAS
108736-35-2

Compound Identifiers & Properties

CAS
108736-35-2
PubChem CID
6918011
SMILES
C[C@H]([C@@H](C(=O)N)NC(=O)[C@@H]1CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)C(C)C)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)[C@@H](CC5=CC6=CC=CC=C6C=C5)N)O
Canonical SMILES
CC(C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](NC(=O)[C@H](N)Cc2ccc3ccccc3c2)CSSC[C@@H](C(=O)N[C@H](C(N)=O)[C@@H](C)O)NC1=O

Names & Synonyms

  • Lanreotide
  • Angiopeptin
  • Ipstyl
  • Lanreotida
  • Lanreotide acetate
  • Lanreotidum
  • Somatulin
  • Autogel
  • Lanreotide Autogel
  • Dermopeptin
  • Somatulina
  • Somatulin-Autogel
  • Somatuline Depot
  • Somatuline LA
  • 188Re-lanreotide
  • 108736-35-2
  • Lanreotide [INN:BAN]
  • AC1OCEWT
  • Lanreotidum [INN-Latin]
  • Lanreotida [INN-Spanish]
  • RefChem:56442
  • Bim-23014
  • UNII-0G3DE8943Y
  • BIM 23014
  • Lanreotide,Lanreotide Acetate
  • C54H69N11O10S2
  • DTXSID60897514
  • 0G3DE8943Y
  • orb1705579
  • 108736-35-2free base
  • CHEMBL1201185
  • SCHEMBL29356077
  • SCHEMBL29402091
  • SCHEMBL29450601
  • BDBM82470
  • 108736-35-2 (free base)
  • H01CB03
  • BIM 23014C
  • DTXCID601326869
  • BIM-23014 C
  • HY-P1959
  • DC 13-116
  • MFCD00873576
  • MFCD03424071
  • Nal-cyclo(cys-tyr-trp-lys-val-cys)-thr-NH2
  • AKOS030573447
  • ACN-049495
  • BAT-010202
  • CID6918011
  • D-Nal-cys-tyr-trp-lys-val-cys-thr-NH2
  • AC-38405
  • BP-43730
  • BP-43731
  • DC 13116
  • DC13-116
  • FL110376
  • C54-H69-N11-O10-S2
  • 118992-92-0
  • DC-13-116
  • CS-0103335
  • Nal-cyclo(Cys-Tyr-Trp-Lys-Val-Cys)Thr-NH2
  • NS00005999
  • C71317
  • (4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2R)-2-amino-3-naphthalen-2-ylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
  • L-Threoninamide, 3-(2-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2-->7)-disulfide
  • naphthyl-cyclo(Cys-Tyr-Trp-Lys-Val-Cys)Thr-NH2
  • A857302
  • B-naphthyl-D-ala-cys-tyr-D-trp*lys-val-cys-thr am
  • Q1707877
  • (4R,7S,10S,13R,16S,19R)-13-((1H-indol-3-yl)methyl)-19-((R)-2-amino-3-(naphthalen-2-yl)propanamido)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-10-(4-aminobutyl)-16-(4-hydroxybenzyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide
  • 3-(2-Naphthyl)-D-ala-cys-tyr-D-trp-lys-val-cys-thr-NH2
  • BETA-(2-NAPHTHYL)-D-ALA-CYS-TYR-D-TRP-LYS-VAL-CYS-THR AMIDE
  • L-Threoninamide, 3-(2-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2-7)-disulfide
  • 2-naphthylalanyl-cyclo(cysteinyl-tyrosyl-tryptophyl-lysyl-valyl-cysteinyl)-threoninamide
  • 3-(2-Naphthyl)alanyl-cystinyl-tyrosyl-tryptophyl-lysyl-valyl-cystinyl-threonine amide
  • 3-(2-Naphtyl)-D-Ala-L-Cys(1)-L-Tyr-D-Trp-L-Lys-L-Val-L-Cys(1)-L-Thr-NH2
  • naphthalenyl-cyclo(cysteinyl-tyrosyl-tryptophyl-lysyl-valyl-cysteinyl)threoninamide
  • (4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-19-[[(2R)-2-amino-3-(2-naphthyl)propanoyl]amino]-N-[(1S,2R)-1-carbamoyl-2-hydroxy-propyl]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
  • (4R,7S,10S,13R,16S,19R)-10-(4-Aminobutyl)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-16-[(4-hydroxyphenyl)methyl]-13-[(1H-indol-3-yl)methyl]-19-{[3-(naphthalen-2-yl)-D-alanyl]amino}-6,9,12,15,18-pentaoxo-7-(propan-2-yl)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide
  • 10-(4-aminobutyl)-N-(1-amino-3-hydroxy-1-oxobutan-2-yl)-19-((2-amino-3-naphthalen-2-ylpropanoyl)amino)-16-((4-hydroxyphenyl)methyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
  • 10-(4-aminobutyl)-N-(1-amino-3-hydroxy-1-oxobutan-2-yl)-19-[(2-amino-3-naphthalen-2-ylpropanoyl)amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
  • 127984-74-1
  • 2-({19-2-amino-3-(naphthalen-2-yl)propanamido-10-(4-aminobutyl)-16-(4-hydroxyphenyl)methyl-13-(1H-indol-3-yl)methyl-6,9,12,15,18-pentaoxo-7-(propan-2-yl)-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl}formamido)-3-hydroxybutanamide
  • 2378114-72-6
  • 3-(2-Naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-threoninamide cyclic (2-7)-disulfide
  • L-Threoninamide, 3-(1-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2-7)-disulfide
  • L-Threoninamide, 3-(2-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2 inverted exclamation marku7)-disulfide